Cubist Systematic Strategies’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-32,335
| Closed | -$489K | – | 4957 |
|
|
2022
Q3 | $489K | Buy |
32,335
+5,313
| +20% | +$61.8K | ﹤0.01% | 3178 |
|
|
2022
Q2 | $203K | Sell |
27,022
-82,588
| -75% | -$582K | ﹤0.01% | 3692 |
|
|
2022
Q1 | $997K | Sell |
109,610
-346,417
| -76% | -$2.67M | 0.01% | 2026 |
|
|
2021
Q4 | $3.2M | Buy |
+456,027
| New | +$4.77M | 0.03% | 973 |
|
|
2021
Q2 | – | Sell |
-72,413
| Closed | -$1.29M | – | 3189 |
|
|
2021
Q1 | $1.29M | Sell |
72,413
-20,505
| -22% | -$354K | 0.02% | 1362 |
|
|
2020
Q4 | $1.25M | Sell |
92,918
-32,977
| -26% | -$398K | 0.02% | 1226 |
|
|
2020
Q3 | $1.48M | Sell |
125,895
-17,832
| -12% | -$217K | 0.02% | 1092 |
|
|
2020
Q2 | $2.12M | Buy |
143,727
+44,420
| +45% | +$657K | 0.04% | 753 |
|
|
2020
Q1 | $1.34M | Sell |
99,307
-28,183
| -22% | -$535K | 0.04% | 657 |
|
|
2019
Q4 | $3.08M | Buy |
127,490
+79,464
| +165% | +$1.65M | 0.06% | 517 |
|
|
2019
Q3 | $923K | Sell |
48,026
-708
| -1% | -$16.2K | 0.02% | 1005 |
|
|
2019
Q2 | $1.44M | Buy |
+48,734
| New | +$1.88M | 0.03% | 844 |
|
|
2019
Q1 | – | Sell |
-16,542
| Closed | -$597K | – | 2473 |
|
|
2018
Q4 | $597K | Sell |
16,542
-6,110
| -27% | -$287K | 0.03% | 849 |
|
|
2018
Q3 | $1.39M | Buy |
+22,652
| New | +$1.46M | 0.08% | 332 |
|
|
2017
Q4 | – | Sell |
-8,106
| Closed | -$394K | – | 2156 |
|
|
2017
Q3 | $394K | Buy |
+8,106
| New | +$442K | 0.02% | 977 |
|
|
2017
Q2 | – | Sell |
-13,300
| Closed | -$603K | – | 1936 |
|
|
2017
Q1 | $603K | Buy |
+13,300
| New | +$593K | 0.04% | 557 |
|
|
2016
Q1 | – | Sell |
-1,299
| Closed | -$32K | – | 1901 |
|
|
2015
Q4 | $32K | Buy |
+1,299
| New | +$30.3K | ﹤0.01% | 1646 |
|
|
2015
Q1 | – | Sell |
-1,300
| Closed | -$38K | – | 2133 |
|
|
2014
Q4 | $38K | Buy |
+1,300
| New | +$33K | ﹤0.01% | 1794 |
|
Cubist Systematic Strategies's AERI Position: Q4 2022 in Review
Cubist Systematic Strategies sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 32,335 shares — an estimated $489K sold.
Cubist Systematic Strategies first reported a position in AERI in Q4 2014 and held it in 18 quarters. The position peaked at $3.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Cubist Systematic Strategies reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Cubist Systematic Strategies sold 32,335 Aerie Pharmaceuticals shares in Q4 2022, an estimated $489K.
- Cubist Systematic Strategies first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 18 quarters.
- Cubist Systematic Strategies's Aerie Pharmaceuticals position peaked at $3.2M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.